Related references
Note: Only part of the references are listed.Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis
Xiao-Dong Mo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies
Meng-Zhu Shen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Shuang Fan et al.
FRONTIERS IN ONCOLOGY (2022)
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
Meng-Zhu Shen et al.
Therapeutic Advances in Hematology (2022)
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
Algirdas Grevys et al.
ISCIENCE (2022)
Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
Jacobo Lopez-Abente et al.
SCIENTIFIC REPORTS (2021)
Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
Jing-Rui Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
Hany Elmariah et al.
LIFE-BASEL (2021)
Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease
Da-Bin Ryu et al.
EXPERIMENTAL HEMATOLOGY (2021)
Kinetics of IgG subclasses and their effects on the incidence of infection after allogeneic hematopoietic stem cell transplantation
Shiro Koh et al.
TRANSPLANT IMMUNOLOGY (2021)
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group
Lan-Ping Xu et al.
BONE MARROW TRANSPLANTATION (2021)
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
Xiao-hui Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease
Meng-Zhu Shen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell Transplantation
Fei-Fei Tang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
Florent Malard et al.
LEUKEMIA (2020)
Beneficial role of CD8+T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting
Attilio Bondanza et al.
BONE MARROW TRANSPLANTATION (2019)
Comparison of reference values for immune recovery between event-free patients receiving haploidentical allografts and those receiving human leukocyte antigen-matched sibling donor allografts
Xuying Pei et al.
FRONTIERS OF MEDICINE (2018)
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD
Nelli Bejanyan et al.
BLOOD ADVANCES (2018)
Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody
Geothy Chakupurakal et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hernatopoietic Cell Transplantation
Peter J. Podgorny et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations
Taiga Nishihori et al.
IMMUNOTHERAPY (2016)
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation
Ying-Jun Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation
Deng-Mei Tian et al.
PLOS ONE (2016)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning
L. J. DeCook et al.
BONE MARROW TRANSPLANTATION (2013)
Treatment and management of graft-versus-host disease: improving response and survival
Catherine Garnett et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia
L. P. Xu et al.
BONE MARROW TRANSPLANTATION (2012)
Diagnosis and management of acute graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Immune Reconstitution Following Unmanipulated HLA-Mismatched/Haploidentical Transplantation Compared with HLA-Identical Sibling Transplantation
Ying-Jun Chang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Evaluation of Alloreactivity in Kidney Transplant Recipients Treated with Antithymocyte Globulin Versus IL-2 Receptor Blocker
L. Cherkassky et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
B7-Mediated Costimulation of CD4 T Cells Constrains Cytomegalovirus Persistence
Ramon Arens et al.
JOURNAL OF VIROLOGY (2011)
Basiliximab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease After Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation
J. Z. Wang et al.
TRANSPLANTATION PROCEEDINGS (2011)
Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections
Elise Corre et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation
Florian Wolfgang Rudolf Vondran et al.
TRANSPLANT INTERNATIONAL (2010)
Innovative approaches to treat steroid-resistant or steroid refractory GVHD
M. Berger et al.
BONE MARROW TRANSPLANTATION (2008)
Allogeneic stem cell transplantation:: low immunoglobulin levels associated with decreased survival
A-C Norlin et al.
BONE MARROW TRANSPLANTATION (2008)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Treatment of acute graft-versus-host disease with prednisolone:: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
Maria Teresa Van Lint et al.
BLOOD (2006)
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist
VAM Funke et al.
BONE MARROW TRANSPLANTATION (2006)
Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease
M Schmidt-Hieber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
G Massenkeil et al.
BONE MARROW TRANSPLANTATION (2002)